BioSpace News Archive

Class-action law firm urges CVET investors who have suffered losses of 50K+ to learn their shareholder rights

Primaria Health, a primary care-focused provider, announced it hired Marty O’Neill as CEO and president.

PharmaCyte Biotech, Inc. announced the latest in its series of Q&A articles that are conducted with some of the key team members of PharmaCyte’s research and development program related to its upcoming clinical trial in locally advanced, inoperable pancreatic cancer.

Amyris, Inc. provided highlights of its business and financial results for the first half of 2019 ended June 30, 2019, which it will review during a conference call after market close on Wednesday, October 2, 2019.

Spectroscopy®, a multimedia platform that promotes the use of spectroscopic instrumentation in applied research, environmental testing, quality control and the life sciences, has named Jacob T. Shelley, of Rensselaer Polytechnic Institute in Troy, New York, the winner of the 2020 Emerging Leader in Atomic Spectroscopy Award.

Economic activity in the manufacturing sector contracted in September, and the overall economy grew for the 125th consecutive month, say the nation’s supply executives in the latest Manufacturing ISM® Report On Business®.

Ryvu Therapeutics and Selvita (WSE: SLV) today announced that the National Court Register of Poland (“KRS”) has recognized the corporate split of the Selvita parent company into two distinct organizations

Humana Inc. announced that its Medicare Advantage plans for 2020 are designed to deliver more ways to care for the whole person through affordable health benefits and wellness programs with added convenience.

The Microbiome Therapeutics Innovation Group, a coalition of companies leading the research and development of FDA-approved microbiome therapeutics and microbiome-based products, announced today three of its member companies will present data from their clinical and research programs at IDWeek 2019, occurring October 2 to 6 in Washington, D.C.

TSO3 Inc. (“TSO3" or the “Company”) (TSX: TOS) today announced that is has completed the previously-announced statutory plan of arrangement under the Business Corporations Act (Québec) pursuant to which a wholly-owned subsidiary of Stryker Corporation acquired all of the issued and outstanding common shares of the Company (the “Shares”) for CAD$0.43 per share in cash (the “Arrangement”